#firstinhuman

First-in-Human to Phase 1 Human Clinical Trial — Scientia's Approach

Every Phase 1 Human Clinical Trial at Scientia Clinical Research is built around people — participants, sponsors, and the patients who need new therapies most. From first-in-human dosing to final results, their Sydney team brings genuine care, deep expertise, and 24/7 support to every study.

First-in-human clinical trial to assess gene therapy for Alzheimer’s disease

PET scan of a human brain with Alzheimer’s disease. Credit: public domain Researchers at University of California San Diego School of Medicine have launched a first-in-human Phase I clinical trial to assess the safety and efficacy of a gene therapy to deliver a key protein into the brains of persons with Alzheimer’s disease (AD) or Mild Cognitive Impairment (MCI), a condition that often precedes…